Skip to main content
Premium Trial:

Request an Annual Quote

Spectrum Solutions Acquires MDx Lab Alimetrix, Array Maker Microarrays Inc.

NEW YORK — Spectrum Solutions said on Tuesday that it has acquired molecular diagnostic lab Alimetrix and microarray manufacturer Microarrays Inc., both located in Huntsville, Alabama.

Financial and other terms of the transactions were not disclosed.

Salt Lake City-based Spectrum said that the acquisitions will help expand its presence in the laboratory testing and custom assay services markets.

"Spectrum is now one step closer to its vision of developing a transformative, decentralized healthcare platform aimed at innovating the way biospecimens are collected and laboratory testing is conducted," Spectrum CEO Stephen Fanning said in a statement.

Alimetrix offers diagnostic tests for a variety of infectious diseases using multiplex PCR, gene target amplification, and sequencing. The company runs a CLIA laboratory and is located at the HudsonAlpha Institute for Biotechnology.

Microarray Inc., founded in 1999, is a spinout from the array core facility at Vanderbilt-Ingram Comprehensive Cancer Center in Tennessee and relocated to the HudsonAlpha Institute in 2008. Both firms had Joel Peek as their president and CSO.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.